Serum miR-30d as a novel biomarker for multiple myeloma and its antitumor role in U266 cells through the targeting of the MTDH/PI3K/Akt signaling pathway

Bingying Zhu(Nantong University), Hui Cong(Shanghai Jiao Tong University), Chunjing Jin(Nantong University), Yafang Pan(Nantong University), Xudong Wang(Tianjin Medical University Cancer Institute and Hospital), Hongmei Chen(Nantong University), Shaoqing Ju(Nantong University), Lei Shen(Jiangsu University), Xiaofen Zhang(Nantong University), Rongrong Jing(Nantong University)
International Journal of Oncology
August 21, 2018
Cited by 19


Related Papers